Hospira (United States) holds 2 active US FDA Type II Drug Master Files and 13 inactive, has DMF or CEP filings on record for 4 active ingredients and is linked to 3 FDA-registered manufacturing sites. 50 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Hospira: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hospira

Overview

Hospira is a subsidiary of Pfizer Inc., specializing in injectable drugs and infusion technologies. The company is known for its development and manufacturing of high-quality biosimilars and generic injectables.

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Hospira holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Hospira holds 2 active (15 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ISOPROTERENOL HYDROCHLORIDE DRUG SUBSTANCEActive2011-08-16
  • VANCOMYCIN HYDROCHLORIDEActive1998-09-01
  • NT100H DRUG SUBSTANCEInactive2012-09-28
  • OXALIPLATIN DRUG SUBSTANCEInactive2010-11-15
  • PAMIDRONIC ACID DRUG SUBSTANCEInactive2006-07-03
  • ATHERO GENICS AGIX-4207 INJECTABLE EMULSIONInactive2001-08-15
  • OFNE ADMIXTURE DRUG PRODUCTSInactive2000-04-28
  • ROGOSIN EMULSIONInactive1999-06-28
  • TEQUIN I.V. (GATIFLOXACIN)Inactive1998-12-21
  • LAMISIL EMULSIONInactive1998-01-29
  • CLEVIDIPINE EMULSIONInactive1995-02-23
  • SPC-100270 EMULSIONInactive1992-12-16
  • PFC EMULSIONInactive1992-11-17
  • TIN ETHYL ETIOPURPURIN (TEP) EMULSION PROCESSING IN KUNGSANGEN AND STOCKHOLM, SWEDENInactive1992-06-29
  • INTRAVENOUS FAT EMULSION PRODUCT 4501Inactive1987-10-05

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Hospira, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

50 FDA enforcement records linked to this company.

  • 4832025-01-17

    Procedures for sterile drug products

  • 4832025-01-17

    Control procedures to monitor and validate performance

  • 4832025-01-17

    Investigations of discrepancies, failures

  • 4832020-01-17

    Acceptance criteria for sampling & testing

  • 4832020-01-17

    Validation lacking for sterile drug products

  • 4832020-01-17

    Investigations of discrepancies, failures

  • 4832020-01-17

    Procedures not in writing, fully followed

  • 4832020-01-17

    Complete instructions, procedures, specifications et. al.

  • 4832020-01-17

    SOPs not followed / documented

  • 4832020-01-17

    Written record of investigation incomplete

  • 4832020-01-17

    Exhaust systems inadequate to control air contamination

  • 4832020-01-17

    In-process conformity - examination, sample testing

  • 4832020-01-17

    Control procedures to monitor and validate performance

  • 4832019-11-21

    Written record of investigation incomplete

  • 4832019-11-21

    Scientifically sound laboratory controls

  • 4832019-11-21

    Investigations of discrepancies, failures

  • 4832018-02-02

    Test devices not meeting specifications

  • 4832018-02-02

    Calibration/Inspection/Checking not done

  • 4832018-02-02

    Procedure Deviations Recorded and Justified

  • recall — Class I2017-05-31

    Presence of Particulate Matter: human hair found within an internal sample syringe.

  • warning_letter2017-02-14

    FDA Warning Letter (drug product)

  • recall — Class III2016-12-14

    Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.

  • recall — Class II2016-11-30

    Lack of Assurance of Sterility: Complaints of broken tips on the ampules.

  • recall — Class II2016-09-21

    Discoloration: Firm received complaints of product discoloration and particulates.

  • recall — Class II2016-07-20

    Crystallization: Product contains particulate identified to be crystallized active ingredient.

  • recall — Class I2016-07-13

    Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter.

  • recall — Class II2016-06-22

    Presence of Particulate Matter: Cardboard

  • recall — Class I2016-06-01

    Presence of Particulate Matter: particulate matter identified as an insect in one vial.

  • recall — Class III2016-05-25

    Failed pH Specifications: Confirmed high out of specification (OOS) results for pH.

  • recall — Class III2016-05-11

    Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.

  • recall — Class II2016-04-27

    Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

  • recall — Class II2016-04-27

    Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

  • recall — Class II2016-04-27

    Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

  • recall — Class II2016-04-27

    Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

  • recall — Class II2016-04-27

    Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

  • recall — Class II2016-04-27

    Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

  • recall — Class III2016-03-02

    Labeling: Incorrect or Missing Lot and/or Exp Date: Confirmed customer report of an incorrect expiration date printed on the primary container labeled "01AUG1017" rather than "01AUG2017".

  • recall — Class I2016-02-24

    Labeling: Incorrect Barcode: Primary bag labeling may be mislabeled with the wrong barcode which scans in as heparin sodium.

  • recall — Class III2015-10-28

    Failed Impurities/Degradation Specifications: Out of Specification(OOS) results for degradation product of etomidate was confirmed during stability testing.

  • recall — Class II2015-09-30

    Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.

  • recall — Class II2015-09-23

    Defective Container: There were customer complaints of cracked and leaking glass vials.

  • recall — Class II2015-07-22

    Crystallization; identified as calcium salt of Ketorolac

  • recall — Class II2015-07-22

    Crystallization; identified as calcium salt of Ketorolac

  • recall — Class II2015-07-22

    Lack of assurance of sterility: Potential channel leaks near the threaded vial port.

  • recall — Class I2015-07-15

    Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.

  • recall — Class III2015-07-15

    Failed pH Specifications: 12 month stability testing

  • recall — Class I2015-06-03

    Non-Sterility: Confirmed customer report of dark, fibrous particulates floating within the solution of the primary container, which were subsequently identified as mold

  • recall — Class I2015-05-20

    Labeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9% in sodium chloride injection.

  • recall — Class I2015-05-13

    Presence of Particulate Matter: Confirmed finding of human hair floating in IV solution.

  • recall — Class II2015-05-06

    Crystallization

For suppliers

Is this Hospira?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.